Kaiyuan Securities released a research report stating that 2026 marks the first year of mass production for humanoid robots, with the critical inflection point now approaching. The focus remains on leading domestic integrators, including Unitree, Zhijin, and UBTECH ROBOTICS (09880), followed by investment opportunities in core supply chains, OEM manufacturers, and standardization. Key insights from Kaiyuan Securities are as follows:

**Sector Rebounds, Investment Window Opens** The humanoid robot sector has shown a notable rebound, with significant capital inflows indicating an upward trajectory. Last week (November 24–28), the broader market rose, with the CSI 300 and STAR 50 indices gaining 1.64% and 3.21%, respectively, while the core humanoid robot sector index surged 6.04%, outperforming the market. Top weekly gainers included Siling (+21.28%), Riying Electronics (+19.74%), Buke (+17.63%), Hengbo (+16.28%), and Longsheng Tech (+11.42%). Lagging performers were Zhongjian Tech (-4.24%), Zhongda Lide (-2.64%), Anpeilong (-0.54%), Zhejiang Rongtai (+0.92%), and Reid (+1.20%).

Kaiyuan Securities attributes the rebound to sector adjustments nearing completion, sufficient risk release, and rationalized industry expectations. Accelerated progress from Tesla overseas and domestic industrial developments further bolster the outlook. With mass production set for 2026, major players entering the field, and policy support likely materializing, the sector’s "strengthening trend and rising prosperity" presents a clear investment opportunity.

**Tesla’s Supply Chain Clarifies, Domestic Capitalization Accelerates** The report outlines Tesla’s robot development and production timeline: 1. **December**: New factory audits to standardize production lines and prepare for 2026 mass production. 2. **Early 2026**: Gen3 robot mass production finalized, with first-tier suppliers confirmed by March. 3. **August 2026**: Second-tier suppliers selected, scaling up manufacturing. 4. **Q3 2026**: Robots begin rolling off production lines.

Tesla VP Tao Lin recently dismissed rumors of "de-Sinicizing" its supply chain, emphasizing no exclusion based on origin. Kaiyuan highlights China’s advantages—complete supply chains, cost-efficient mass production, and global capacity—and recommends two investment themes: 1. **High-certainty supply chain entrants**: Integrators, bearings, structural components, and linear modules (including lead screws). 2. **Tech evolution**: Dexterous hands (micro lead screws, motors, tendon systems), rotary modules (gearboxes), sensors (tactile/force control), and motors.

**Domestic Policy and Industry Synergy Drive Mass Production** 1. Xiaomi’s Lei Jun announced plans for humanoid robots to operate in factories within five years, extending to households—Xiaomi’s supply chain warrants attention. 2. Unitree invested ¥1.24 billion in a Ningbo "super factory," benefiting local supply chains. 3. Changan Auto established a ¥225M joint venture (Tianshu Robotics) to advance humanoid tech and auto-robot synergy, signaling sector potential. 4. Regulatory moves, including committee appointments and policy frameworks, suggest supportive measures are imminent.

**Key Stocks** - **Integrators**: Lens Tech, Minth Group - **Bearings**: Wuzhou Xinchun, Reid; beneficiary: Wanxiang Qianchao - **Structural components**: Lens Tech, Changying Precision - **Joints**: Zhenyu Tech; beneficiaries: Top Group, Sanhua, Yinlun - **Dexterous hands**: Zhenyu Tech, Wuzhou Xinchun, Jundeda; beneficiaries: Zhejiang Rongtai, Riying Electronics, Hengbo, Dechang - **Planetary roller screws**: Zhenyu Tech, Wuzhou Xinchun; beneficiary: Hengli Hydraulic - **Gearboxes**: Longsheng Tech - **Lightweighting**: Weike Tech; beneficiaries: Xusheng, Xingyuan Zhuomei, Daimei - **Motors**: JL Mag, Xinzhi Group, Weichuang Electric, Buke - **Domestic chain**: Zhejiang Headman, Jizhi; beneficiaries: Taotao, Zhongda Lide

**Risks**: Macroeconomic volatility, delayed robot production, or supply chain bottlenecks.